Accelerated response and reduced chemotherapy with ruxolitinib-based regimen therapy in pediatric hemophagocytic lymphohistiocytosis: a retrospective comparison with HLH-94 regimen

ObjectiveTo compare the efficacy of a Ruxolitinib-based regimen versus the conventional HLH-94 protocol in children with newly diagnosed hemophagocytic lymphohistiocytosis (HLH).MethodsThis single-center, retrospective historical control study enrolled 67 pediatric HLH patients who met the HLH-2004...

Descrición completa

Detalles Bibliográficos

Principais autores:	Na Song, Haiyan Luo, Benshan Zhang, Pan Wu, Xiaoqin Zhang, Qianxiu Fan, Huimin Xu, Zilin Gong, Chenli Zhou, Shiyi Hu, Xinping Zhang, Jiaotian Huang, Haixia Yang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-03-01
Series:	Frontiers in Immunology
Assuntos:	chemotherapy reduction children efficacy hemophagocytic lymphohistiocytosis retrospective study ruxolitinib
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1769006/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!